CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators
14,662
edits
Allergenic Products Advisory Committee: Difference between revisions
m
Text replacement - "{{<span class="error">Expansion depth limit exceeded</span>" to "{{Organization"
m (Text replacement - "{{Organization" to "Catergory:Orgs {{Organization") Tag: Reverted |
m (Text replacement - "{{<span class="error">Expansion depth limit exceeded</span>" to "{{Organization") Tag: Reverted |
||
| Line 1: | Line 1: | ||
[[Catergory:Orgs]] | [[Catergory:Orgs]] | ||
{{ | {{Organization|OrganizationName=Allergenic Products Advisory Committee | ||
|OrganizationType=Boards, Commissions, and Committees | |OrganizationType=Boards, Commissions, and Committees | ||
|Mission=The Allergenic Products Advisory Committee advised the FDA on the safety, effectiveness, and labeling of allergenic biological products for human use until its termination in 2024. It evaluated data on products for allergy diagnosis, prevention, and treatment, providing recommendations to the FDA Commissioner to ensure public health standards. | |Mission=The Allergenic Products Advisory Committee advised the FDA on the safety, effectiveness, and labeling of allergenic biological products for human use until its termination in 2024. It evaluated data on products for allergy diagnosis, prevention, and treatment, providing recommendations to the FDA Commissioner to ensure public health standards. | ||
| Line 18: | Line 18: | ||
'''Allergenic Products Advisory Committee (APAC)''' was an advisory body within the Food and Drug Administration (FDA), established on July 9, 1984, to assess allergenic biological products like extracts used for diagnosing and treating allergies, until its termination on July 9, 2024. Comprising nine core voting members with expertise in allergy, immunology, and related fields, APAC reviewed data on safety, efficacy, and labeling, holding infrequent meetings—such as those in 2016, 2019, and 2021—before its duties were absorbed by the [[Vaccines and Related Biological Products Advisory Committee]] (VRBPAC) due to low utilization. | '''Allergenic Products Advisory Committee (APAC)''' was an advisory body within the Food and Drug Administration (FDA), established on July 9, 1984, to assess allergenic biological products like extracts used for diagnosing and treating allergies, until its termination on July 9, 2024. Comprising nine core voting members with expertise in allergy, immunology, and related fields, APAC reviewed data on safety, efficacy, and labeling, holding infrequent meetings—such as those in 2016, 2019, and 2021—before its duties were absorbed by the [[Vaccines and Related Biological Products Advisory Committee]] (VRBPAC) due to low utilization. | ||
{{ | {{Organization|url=https://www.fda.gov/advisory-committees/allergenic-products-advisory-committee}} | ||
==Mission== | ==Mission== | ||